-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
Canopy Growth Stock: No One is Paying 12 Times Sales for Anything
CGC stock has begun laying off people and closing greenhouses, husbanding cash as the coronavirus ravages the stock of its biggest investor, which makes Corona beer.
Aphria Stock Is a Solid Pick for Speculators Amid Market Turmoil
Along with just about every other cannabis stock, Aphria has been in a tailspin. And the implosion of the overall market has made things even worse. But for investors looking for a speculation, this could be a good one.
Cronos Stock Watchers Should Wait For Further Declines Before Buying
Add in the Altria connection, and Cronos stock could be a big winner. But that's over a long time horizon. Until then, the best play is to wait for shares to reach a more reasonable valuation.
Aphria Needs Strong Sales Growth to Rise High Again
What does the future look like for Aphria stock? It depends on its success in growing market share and international sales.
Can Aurora Cannabis Climb Its Massive Wall of Worry?
Aurora stock has a massive wall of worry it has to climb, and I expect more than a few missteps that eventually lead to total collapse.
Don’t Lump OrganiGram Stock With All the Other Downtrodden Pot Stocks
Even during a challenging time for the broader canna-business, there are still a few good reasons to hold onto OrganiGram stock.
Cronos Stock Just Raised a Massive Red Flag
Cronos has delayed its quarterly and annual earnings report by at least two weeks while it conducts an audit of its financials. Until that audit is complete, the stock will likely underperform.
Patience Will Be Rewarded for Investors in Beaten-Up Cronos Stock
It may take awhile for it to materialize, but beaten-up Cronos stock could eventually turn into a multi-bagger for investors.
Approaching $1, Aurora Cannabis Stock Is Not for the Faint of Heart
Aurora stock is continuing its downtrend and bullish momentum left the cannabis space. Investors must proceed with caution.
Constellation Brands’ Sad Fate Seems Written in the Stars
Constellation Brands and STZ stock once earned a premium for its CGC investment. Now it seems guaranteed to head lower.
The Bull Case for New Age Beverages Stock Still Isn’t Strong Enough
Although New Age Beverages has an exciting product pipeline, it still isn't a good enough reason to to own NBEV stock right now.
Aurora Cannabis Is Approaching Baseball’s Mendoza Line
Aurora stock could hit the stock market's version of the Mendoza Line, the $1 mark, if companies can't take market share from street dealers.
It’s High Time Investors Buy Some Canopy Growth Shares
After Canopy's solid earnings report, charts are indicating that it has hit a bottom. It's time for investors to pick up some CGC stock now.
Canopy Growth’s Future Is Still Very Bright
Canopy Growth reported strong sales numbers and updated investors on its U.S. expansion. CGC stock still looks bright.
Even Under $2, Aurora Stock Remains Unattractive
Accelerated cash burn is a concern for Aurora stock, coupled with sluggish growth in medicinal and recreational cannabis. Further ACB equity dilution coming.
Recent Aurora Stock News Leaves Investors Wondering: Buy, Hold or Sell?
After the recent quarterly report and the general outlook, it is not prudent to recommend Aurora stock as a buy. Covered calls or put spreads present an alternative to play ACB.
